A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
OTHER

Inhaled nitric oxide (NO)

The Nitric Oxide Generation and Delivery System is used to deliver nitric oxide for inhalation therapy into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user, to the patient throughout the inspired breath.

OTHER

air

use air(21%O2)as the placebo of inhaled treatment

Trial Locations (1)

210000

RECRUITING

The First Affiliated Hospital with Nanjing Medical University, Nanjing

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novlead Inc.

INDUSTRY

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT05896800 - A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter